Journal
FEBS LETTERS
Volume 588, Issue 3, Pages 422-428Publisher
WILEY
DOI: 10.1016/j.febslet.2013.12.021
Keywords
Prohibitin; Human cholangiocarcinoma; Localization shift; Interaction
Funding
- National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]
- Science and Technology Foundation of Xiamen, China [3502Z20133009]
- National Nature Science Foundation of China [81101502]
Ask authors/readers for more resources
In this study, we aimed to investigate the aberrant expression and shift in localization of prohibitin (PHB) during apoptosis of human cholangiocarcinoma cells. Our study demonstrated that PHB was expressed primarily in the cytoplasm and only a little in the nucleus. However, PHB expression significantly decreased, and its localization shifted from the cytoplasm to the nucleus during apoptosis. PHB co-localized with AIF, Rb, p53, and c-Fos, but the region of co-localization was altered after treatment. Meanwhile, we detected a direct interaction between PHB and both p53 and Rb in Mz-ChA-1 cells. These results suggest that the altered localization and expression of PHB, as well as its co-localization with related oncogenes and tumor suppressor genes, can affect the apoptosis of Mz-ChA-1 cells. Structured summary of protein interactions: AIF and PHB colocalize by fluorescence microscopy (View interaction) Rb and PHB colocalize by fluorescence microscopy (View interaction) c-Fos and PHB colocalize by fluorescence microscopy (View interaction) PHB and p53 colocalize by fluorescence microscopy (View interaction) (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available